GSK vaccines

Active Awarded Last action

Contract number
15F06726F0000234
Awardee
Awarding agency
Obligated
$113,000

Award facts

Contract value 100% obligated
$113,000.00 Current and potential, with all options
Completion date 78% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27701, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 $8,000
Funding Only Action P00002 $25,000
Funding Only Action P00001 $56,000
Original award $24,000

About this award

The Defense Logistics Agency Headquarters Division issued a BPA call to Glaxosmithkline, LLC for GSK vaccines with a ceiling value of $113,000.00 on February 27, 2026, under BPA 15F06722A0000187. Place of performance is Durham, North Carolina. The call is firm fixed price with an ultimate completion date of December 31, 2026. No set-aside was used. The source does not specify the scope of vaccines, delivery schedule, or other performance requirements beyond the product category.

Quick answers

Who was awarded contract 15F06726F0000234?

15F06726F0000234 was awarded to Glaxosmithkline, LLC by Headquarters Division (Federal Bureau of Investigation) on February 27, 2026.

How much is contract 15F06726F0000234 worth?

The government has obligated $113,000 on 15F06726F0000234.

Is contract 15F06726F0000234 an order under another contract?

Yes. 15F06726F0000234 is a BPA call under 15F06722A0000187, a blanket purchase agreement.

Was contract 15F06726F0000234 competed?

The extent of competition for 15F06726F0000234 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award